Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Additionally, there was a significant correlation between physical activity and both lower glycaemia and higher vitamin D levels (Figure 2C,D).

Source: 3.2. Correlation Between Physical Activity and Depression and Chronic Fatigue. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Factors Affecting Health-Related Quality of Life in Patients After a Liver Transplant: A Cross-Sectional, Single-Centre, Large-Cohort Study

Source: Article title.

These patients were age: and gender-matched to 275 (138 males and 137 females) individuals with no liver disease or serious medical conditions affecting their HRQoL.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Factors Affecting Health-Related Quality of Life in Patients After a Liver Transplant: A Cross-Sectional, Single-Centre, Large-Cohort Study

Cohort study · Journal of Clinical Medicine · 2025

Original publication title

Factors Affecting Health-Related Quality of Life in Patients After a Liver Transplant: A Cross-Sectional, Single-Centre, Large-Cohort Study

Katarzyna Kotarska; Ewa Wunsch; Jerzy Przedlacki; Maciej Wójcicki; Joanna Raszeja-Wyszomirska; Jolanta Małyszko; Piotr Milkiewicz

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background/Objectives:

Over the past decades there has been a remarkable improvement in the clinical outcomes and prognoses after orthotopic liver transplantation (OLTx). Health-related quality of life (HRQoL) has emerged as an important concept for assessing the success of this procedure. We aimed to assess critical aspects of HRQoL in patients transplanted at our centre.

Methods:

We recruited 420 OLTx recipients and divided them into three groups based on the time since surgery. Two hundred and seventy-five controls were matched for age and gender. The Medical Outcomes Study Short Form (SF-36), International Physical Activity Questionnaire, Patient Health Questionnaire-9 (PHQ-9), and the Modified Fatigue Impact Scale (MFIS) were used to assess HRQoL, physical activity levels, depression, and chronic fatigue, respectively.

Results:

Compared to controls, OLTx patients exhibited grossly comparable HRQoL except for the physical component score (PCS) and mental domains of the SF-36. There was a significant correlation between the impairment of the PCS and depression and between the PCS and chronic fatigue. Physically active patients scored significantly lower in the MFIS, and there was a strong correlation between depression and chronic fatigue. Females exhibited more pronounced symptoms of depression and chronic fatigue than males but comparable physical activity levels and general QoL. Unemployed patients had significantly higher scores in the PHQ-9/MFIS.

Conclusions:

The general HRQoL of OLTx patients was similar to controls. However, patients were less physically active and more frequently unemployed. As depression and chronic fatigue occurred more often in females, particular attention should be paid to their psychiatric assessment.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Orthotopic liver transplantation (OLTx) remains the only curative treatment for patients with end-stage liver disease. Currently, the five-year survival in OLTx patients exceeds 80% due to substantial improvements in managing technical issues, immunosuppression, and the management of post-transplant complications. Given these advances, issues related to patient health-related quality of life (HRQoL) and mood disturbances such as depression and chronic fatigue have emerged as pivotal for assessing the true benefit of this treatment modality [1]. Depression, in particular, may be of considerable importance, as it can not only affect patients’ compliance, but it also has a stronger negative effect on patients’ HRQoL than somatic symptoms [2].

In addition, while chronic fatigue usually decreases after the procedure, it remains in a significant proportion of patients after OLTx and, for some, may be their most distressing symptom [3,4,5].

Physical activity plays a crucial role in maintaining good health. This may be particularly important in patients who have received OLTx, as many remain sedentary with no or minimal physical activity before their operation [1]. Additionally, immunosuppressive treatments may increase various metabolic risks such as hypertension, diabetes or hyperlipidaemia. A recent study has demonstrated that a lack of physical activity leading to obesity and other metabolic problems significantly affects survival in OLTx recipients [6]. Thus, objective assessments of activity levels are essential for patient long-term survival.

Returning to work should also be considered an important outcome parameter after a transplant, as it helps patients come back to everyday activities [7,8]. Unfortunately, a significant proportion of patients remain unemployed after OLTx. Currently, the literature on this subject provides conflicting data. Therefore, in this study, we aimed to assess vital factors associated with patients’ HRQoL in a large cohort of OLTx patients treated at our centre. In particular, we aimed to investigate whether the procedure has a negative impact on perceived general health by comparing scores from widely used patient-reported outcome measures (PROMs) between patients and matched controls.

Additionally, we explored whether liver transplantation significantly affects levels of physical activity. Other key areas of interest included the willingness to return to work and its potential positive influence on symptoms of depression and chronic fatigue. Finally, we examined whether gender plays a role in the prevalence or severity of common symptoms impacting health-related quality of life (HRQoL).

Source: 1. Introduction Source: 1. Introduction

Study methods

What methods does the paper describe?

2.1. Patients

The study includes 420 liver transplant recipients (239 males and 181 females) under care at our unit and out-patients clinic. These patients were age: and gender-matched to 275 (138 males and 137 females) individuals with no liver disease or serious medical conditions affecting their HRQoL. Control group was recruited from patients’ families and attendees of various courses on popular science issues conducted by the authors of this manuscript. All patients and control subjects were included in the study from October 2017 until March 2020, when the study was stopped due to the COVID-19 pandemic.

All patients were enrolled in the study at least six months after undergoing transplant surgery. Study patients were clinically stable and did not suffer from severe co-morbidities that could have significantly affected their HRQoL or physical activity, such as malignant neoplasms, uncontrolled diabetes, renal failure requiring dialysis, New York Heart Association II heart failure, physical disabilities, orthopaedic or rheumatoid joint diseases, or pulmonary diseases. Patients were divided into three groups depending on the amount of time since their OLTx: 6 to 12 months after OLTx (76 patients [18%], group I), 13 to 36 months after OLTx (145 patients [35%], group II), and >37 months after OLTx (199 [47%], group III).

Demographic data were collected using a self-developed questionnaire that included basic information regarding education, marital and financial status, existing addictions, and included simplified questions on general health and physical activity (Supplementary Materials S1 Questionnaire).

2.2. Assessment of Health-Related Quality of Life

The HRQoL was assessed using the Medical Outcomes Study Short Form (SF-36). The SF-36 is the most widely used and extensively validated generic questionnaire for assessing HRQoL in various clinical settings and populations [9]. It consists of 36 items, grouped into eight domains: physical health domains (physical functioning, role limitations due to physical problems, bodily pain, and general health) and mental health domains (vitality, social functioning, role limitations due to emotional issues, and mental health).

Each domain is scored between 0 and 100 points, with higher scores indicating better HRQoL. Two summary scores, the physical (PCS) and mental components (MCS), were obtained as a median value calculated based on the corresponding domains. This study was carried out under a licenced approval certificate (CT132326/OP012559) for the use of the SF-36 questionnaire.

2.3. Assessment of Physical Activity

To assess physical activity, the Polish long version of the International Physical Activity Questionnaire (IPAQ) [10] was used. IPAQ is an instrument for monitoring levels of physical activity of an adult population between 15 and 69 years of age and was developed for surveillance activities and to guide policy development related to health-enhancing physical activity across various life domains. The long version of the IPAQ comprises 27 items and investigates four physical activity domains (work, leisure, chores, and transport), as well as using time spent sitting as a proxy for sedentary behaviour [11].

Physical activity is reported as a continuous score by domain and intensity of the physical activity (moderate or vigorous) or walking. The energy cost of an activity was expressed in METs (metabolic equivalent tasks). A MET is the ratio of the energy expenditure during a given activity divided by the resting energy expenditure [10]. In this study, physical activity energy expenditure was calculated according to the following formula (in MET-min·week−1): number of days spent performing the activity × average duration of the activity per day × energy cost of the activity.

2.4. Assessment of Depressive Symptoms

The Patient Health Questionnaire-9 (PHQ-9) is a self-administered screening tool for depressive symptoms as defined in the Diagnostic and Statistical Manual IV and was initially designed as a part of the Primary Care Evaluation of Mental Disorders [12]. PHQ-9 scores range from 0 to 27 points. Scores of 5, 10, 15, and 20 points correlate with mild, moderate, moderately severe, and severe depression, respectively.

2.5. Assessment of Chronic Fatigue

The Modified Fatigue Impact Scale (MFIS) is a revised form of the original Fatigue Impact Scale. The Polish version was used in this study [13]. This 21-item scale provides a global score and generates three sub-scales that measure the effects of fatigue in terms of physical, cognitive and psychosocial functioning. Each item is rated by the respondent on a scale from 0 (never) to 4 (almost always). Scores are calculated for each of its three sub-scales: physical (9 items, cumulative score range 0 to 36), cognitive (10 items, cumulative score range 0 to 40), and psychosocial (2 items, cumulative score range 0 to 8) These scores are combined for a total MFIS score (range 0 to 84) [14].

2.6. Assessment of Bone Mineral Density

Bone mineral density (BMD) was measured in the lumbar spine (L1: L4) and total hip by dual-energy X-ray absorptiometry (GE Lunar Prodigy, Madison, WI, USA; software enCORE version 14.1) using automatic scan modes. Osteopenia and osteoporosis were defined according to World Health Organisation diagnostic criteria. BMD values were expressed in g/cm2 along with z-scores (standard deviation from the mean BMD for healthy, age-matched, gender-specific subjects) and t-scores (standard deviation from the mean BMD for young, healthy individuals).

2.7. Statistics

Descriptive statistical methods were used to analyse all variables. The distribution of continuous variables was visually inspected by histograms and presented as median and ranges. Categorical data are described using the number of observations and absolute frequencies. The Mann: Whitney test or the Kruskal: Wallis equality-of-populations rank test, were applied as appropriate to calculate the differences between sub-groups. Correlation analyses were performed using the Spearman rank correlation method. Prevalence comparisons between groups were performed using two-tailed Fisher’s exact test or Yates corrected Chi-squared test.

Stata 18.0 (StataCorp LLC, College Station, TX, USA) was used for all calculations and graphs. A value of p < 0.05 was considered statistically significant.

Source: 2. Material and Methods Source: 2. Material and Methods Source: 2. Material and Methods Source: 2. Material and Methods Source: 2. Material and Methods Source: 2. Material and Methods Source: 2. Material and Methods

Correlation Between HRQoL and Physical Activity, Depression, and Chronic Fatigue

Results: Correlation Between HRQoL and Physical Activity, Depression, and Chronic Fatigue

For this analysis, summaries of the PCS and MCS were used. As shown in Figure 1B,C, there was a significant correlation between a pronounced impairment of the PCS and depression and between the PCS and chronic fatigue. No statistically significant correlation was seen between the PCS and physical activity as measured by the IPAQ. Additionally, there was no correlation between MCS and IPAQ, and depression and chronic fatigue. These data are summarised in Figure 1.

Source: 3.1. Correlation Between HRQoL and Physical Activity, Depression, and Chronic Fatigue

Correlation Between Physical Activity and Depression and Chronic Fatigue

Results: Correlation Between Physical Activity and Depression and Chronic Fatigue

There were negative correlations between physical activity and depressive symptoms and between physical activity and chronic fatigue (Figure 2A,B). Additionally, there was a significant correlation between physical activity and both lower glycaemia and higher vitamin D levels (Figure 2C,D).

Source: 3.2. Correlation Between Physical Activity and Depression and Chronic Fatigue

Correlation Between Depression and Chronic Fatigue

Results: Correlation Between Depression and Chronic Fatigue

There was a significant correlation between PHQ-9 and MFIS scores. More depressed patients complained of more pronounced chronic fatigue (Figure 3).

Source: 3.3. Correlation Between Depression and Chronic Fatigue

Results: Comparison of Male and Female Patients

Female patients had significantly lower BMIs than males. They also had more pronounced symptoms of depression and chronic fatigue but comparable physical activity levels and general quality of life scores with males (Table 4).

Table 4

Comparison of male and female patients with regard to analysed factors affecting health-related quality of life.

FeatureMales (n = 239)Females (n = 181)p Value
Age (years)52.5 (21 to 80)54 (21 to 74)0.30
BMI (kg/m2)26.7 (17.2 to 41.9)25.0 (15.6 to 40.0)0.004
SF-36 PCS (points)70.0 (23.7 to 85.0)67.5 (26.6 to 88.7)0.72
SF-36 MCS (points)50.0 (26.9 to 68.7)50.0 (21.9 to 72.5)0.79
IPAQ Total MET2550 (66 to 41,328)2376 (49 to 36,582)0.45
IPAQ Total sitting time (minutes/week)2520 (14 to 5580)2100 (21 to 5880)0.12
PHQ-9 (points)3 (0 to 27)5 (0 to 25)<0.0001
MFIS Physical (points)9 (0 to 36)16 (0 to 34)<0.0001
MFIS Cognitive (points)7 (0 to 40)13 (0 to 39)<0.0001
MFIS Psychosocial (points)2 (0 to 8)3 (0 to 8)<0.0001
MFIS Score (points)20 (0 to 84)32 (0 to 72)<0.0001

Continuous variables presented as median and range. The Mann: Whitney test. Abbreviations: IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; PHQ-9, Patient Health Questionnaire-9; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary.

Source: 3.4. Comparison of Male and Female Patients Source: 3.4. Comparison of Male and Female Patients

Results: Employment

Male patients were more frequently employed (65% vs. 50%, p = 0.004). Employed patients were also significantly younger and typically had a better PCS on the SF-36. Additionally, measures of depression and chronic fatigue were significantly better in employed than in unemployed subjects (Table 5).

Table 5

Comparison of employed and unemployed patients with regard to analysed factors affecting health-related quality of life.

FeatureUnemployed (n = 229)Employed (n = 191)p Value
Male gender (n, %)115 (50%)124 (65%)0.004
Age (years)54.3 ± 12.045.7 ± 11.9<0.0001
BMI (kg/m2)26.9 ± 4.725.8 ± 4.40.02
SF-36 PCS (points)65.0 ± 13.067.3 ± 11.80.06
SF-36 MCS (points)49.6 ± 7.649.4 ± 8.30.77
IPAQ Total MET2140 (66 to 36,582)2826 (49 to 41,328)0.008
IPAQ Total sitting time (minutes/week)2434.6 ± 1068.72533.0 ± 1099.30.36
PHQ-9 (points)6.2 ± 5.84.4 ± 4.4<0.0001
MFIS Physical (points)13.9 ± 8.59.9 ± 7.5<0.0001
MFIS Cognitive (points)12.7 ± 8.88.9 ± 7.3<0.0001
MFIS Psychosocial (points)3.0 ± 2.22.1 ± 1.8<0.0001
MFIS Score (points)29.6 ± 18.220.9 ± 15.4<0.0001

For continuous variables: median and range values, the Mann: Whitney test. For categorical data: number of observations and absolute frequencies, the Chi-square test. Abbreviations: IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; PHQ-9, Patient Health Questionnaire-9; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary.

Source: 3.5. Employment Source: 3.5. Employment

Discussion

In this study, we focused on the factors affecting the health-related quality of life of patients who underwent OLTx by analysing a large cohort of patients at our centre. To the best of our knowledge, this is the largest group of post-liver transplant patients investigated for HRQoL variables reported from a single centre. We have a long-lasting interest in various aspects of quality of life factors in patients with various liver conditions both before and after a transplant [15,16,17].

Our main findings can be summarised as follows: (i) liver transplantation does not appear to have a substantial impact on overall health-related quality of life (HRQoL); (ii) patients who have undergone liver transplantation are generally less physically active compared to carefully matched controls; (iii) transplant recipients who return to work after surgery tend to report lower levels of depression and chronic fatigue; and (iv) female patients tend to experience higher levels of depression and chronic fatigue than their male counterparts following the transplant procedure.

Indeed, when compared to age: and gender-matched controls, our patients had comparable HRQoL scores except for the PCS and MCS on the SF-36. This finding confirms the results of previous studies that have found impaired physical and mental coping strategies after surgery [18]. It has been shown that the majority of patients are more concerned about their HRQoL than longevity [18]. Hence, OLTx should aim to lead patients to a normal HRQoL, while impaired physical functioning should focus our attention on this issue and ways to improve it [19,20,21].

Of note, the patients in our study did not report more pronounced symptoms of depression or chronic fatigue compared to controls, which is in contrast to other findings [22].

It has been demonstrated that during the first six months after a liver transplant, a majority of HRQoL factors show significant improvement. Therefore, in this study, we included only patients who had undergone transplant surgery at least six months previously. We divided these patients into three groups depending on the post-surgical period, i.e., between 6 and 12 months, between 12 and 36 months, and above 37 months. These groups were comparable in terms of their clinical status and liver biochemistry.

Furthermore, they did not differ regarding the analysed parameters of health-related quality of life. These results allowed us to use the entire group of transplanted patients for further analyses.

Physical activity is of particular importance in patients who undergo OLTx, as it not only improves general health but also exerts a positive effect on HRQoL [1,23,24,25]. However, an adequate methodology for the precise assessment of physical activity in transplant patients is lacking. This problem has recently been defined as a key unmet need in contemporary transplant hepatology [1]. It has been postulated that liver transplant teams should evaluate the fitness of their patients at discharge and design realistic, long-term exercise programmes aimed at achieving standards that have been established for the general population.

This is of critical importance given a recent study that has highlighted the increasing proportion of physically inactive patients at risk of metabolic problems [6]. That study demonstrated that as many as 73% of transplant patients are either overweight or obese, leading to significantly increased post-transplant mortality [6]. Our study showed that higher physical activity levels correlated with lower chronic fatigue. This confirms previous findings from a study investigating a small group of patients from the Netherlands [3] and further supports the observation that physical exercise alleviates fatigue and improves QoL [5].

We also found a trend towards a correlation between physical activity and better scores in the PHQ-9, which suggests physical activity may have a protective effect against depression. This finding is in line with observations in liver transplant patients [5,22] and in non-transplant settings [26,27,28]. We also found a significant correlation between physical activity and lower glycaemia and higher vitamin D3 levels, confirming the beneficial effects of physical activity on metabolic status.

Several studies have shown that female patients with various health conditions have a worse HRQoL [29,30,31]. The reasons for this remain to be elucidated. While our study found that general HRQoL was not impaired in females after receiving a transplant, there was a striking difference regarding depression and chronic fatigue, with female patients scoring higher in both depression and chronic fatigue questionnaires than males. This finding requires further investigation, preferably with studies that involve a psychologist, to obtain further insight into this phenomenon.

The main aims of liver transplantation are to increase the length and quality of a patient’s life and enable their return to normal life, including work [8,32]. Resuming full productivity should be considered an essential outcome parameter after a solid organ transplant, as it is associated with returning to normal social life, accomplishing personal goals, and improving financial status and self-esteem [33,34]. Although the majority of liver transplants are performed on subjects of working age, a significant proportion do not return to work.

Various studies have shown that between 22% and 60% of patients restart work after OLTx [35,36,37]. A large study based on United Network for Organ Sharing data, which included nearly 22,000 patients, found that only 24% were employed within 24 months after the procedure [8]. The demographic variables independently associated with employment included work activity before OLTx, age between 18 and 40 years, being male, having a college degree, and being Caucasian.

Patients receiving transplants for alcoholic liver disease also had the lowest rate of employment when compared to other indications. While a detailed analysis of this issue was not the main goal of our study, we found that approximately 45% of our patients were employed. Similarly to other studies, males and younger patients were more likely to return to work. We also found that HRQoL, as measured with the SF-36, was comparable between employed and unemployed subjects. Employment also showed a highly significant correlation with lower fatigue scores and less depression in the PHQ-9.

Thus, returning to work appears to have a positive effect on a patient’s mood and fatigue levels, although depression and pronounced fatigue may also preclude commencing employment.

This study has some limitations. First, this was a cross-sectional design. Second, the patients were divided into three groups based on the time after transplantation, and despite these being large cohorts, each group consisted of different patients, which may have decreased the value of our findings. Third, as the data were obtained from patient self-reporting, there may be some bias. Finally, there are no transplant-specific HRQoL questionnaires; thus, most studies, including this one, use generic forms such as the SF-36 or the PHQ-9.

In conclusion, this study showed that important markers of health-related quality of life are similar between liver transplant patients and healthy individuals, confirming that OLTx is both life-saving and offers patients an adequate HRQoL. Unfortunately, transplant patients were also found to be less physically active. Therefore, efforts should be made to encourage these patients to undertake regular exercise. Returning to work had a positive effect on patients, potentially reducing depression and chronic fatigue. As female patients were more frequently depressed and chronically fatigued, adequate counselling and, if necessary, proper treatment should be considered.

Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion

Results

Clinical and demographic data of the patients are summarised in Table 1 and Table 2. Comparisons between the analysed patients and the control group are shown in Table 3.

All three patient groups were comparable in terms of their demographic, clinical, and health-related quality of life factors. There was no statistically significant difference between groups when the period after OLTx was analysed concerning HRQoL, physical activity, depression, or chronic fatigue (Table 1 and Table 2).

There were also no significant differences in sociodemographic variables between patients and controls except for employment, health status, and physical activity levels, as assessed using general questions from a self-prepared questionnaire (Table 3). In the SF-36, transplant patients had significantly worse HRQoL scores than controls in the domains of physical functioning, role, physical and mental health, and in the physical and mental component scores (PCS and MCS, respectively). Transplant patients were also less physically active (Table 3).

3.1. Correlation Between HRQoL and Physical Activity, Depression, and Chronic Fatigue

For this analysis, summaries of the PCS and MCS were used. As shown in Figure 1B,C, there was a significant correlation between a pronounced impairment of the PCS and depression and between the PCS and chronic fatigue. No statistically significant correlation was seen between the PCS and physical activity as measured by the IPAQ. Additionally, there was no correlation between MCS and IPAQ, and depression and chronic fatigue. These data are summarised in Figure 1.

3.2. Correlation Between Physical Activity and Depression and Chronic Fatigue

There were negative correlations between physical activity and depressive symptoms and between physical activity and chronic fatigue (Figure 2A,B). Additionally, there was a significant correlation between physical activity and both lower glycaemia and higher vitamin D levels (Figure 2C,D).

3.3. Correlation Between Depression and Chronic Fatigue

There was a significant correlation between PHQ-9 and MFIS scores. More depressed patients complained of more pronounced chronic fatigue (Figure 3).

3.4. Comparison of Male and Female Patients

Female patients had significantly lower BMIs than males. They also had more pronounced symptoms of depression and chronic fatigue but comparable physical activity levels and general quality of life scores with males (Table 4).

3.5. Employment

Male patients were more frequently employed (65% vs. 50%, p = 0.004). Employed patients were also significantly younger and typically had a better PCS on the SF-36. Additionally, measures of depression and chronic fatigue were significantly better in employed than in unemployed subjects (Table 5).

3.6. Osteoporosis

Features of osteoporosis and osteopenia were seen in 206 (49%) patients. There was no association between bone density and post-transplant time or physical activity levels (Supplementary Table S1).

Table 1

Clinical and demographic data on analysed groups of patients.

FeatureGroup I (n = 77)Group II (n = 145)Group III (n = 198)p Value
Age (years)49 (21 to 70)54 (21 to 80)54 (21 to 74)0.14
Male gender (n, %)45 (58.4%)81 (56.3%)113 (56.8%)0.88
BMI (kg/m2)25.2 (18.2 to 35.5)26.5 (17.9 to 41.9)26.1 (15.6 to 39.0)0.14
Aetiology (n, %) 0.04
Alcohol-related18 (23.4%)31 (21.4%)24 (12.2%)
Autoimmune30 (39.0%)41 (28.3%)65 (33.0%)
Viral8 (10.3%)39 (26.9%)49 (24.8%)
Other21 (27.3%)34 (23.4%)59 (30.0%)
Biochemistry
Hb (g/dL)13.4 (9.2 to 17.6)13.9 (8.1 to 17.6)14.0 (8.6 to 19.2)0.03
Platelets (tys/μL)174 (109 to 404)180 (104 to 402)179 (100 to 429)0.93
AST (IU/L)25 (12 to 319)25 (2 to 505)26 (11 to 555)0.49
ALT (IU/L)28 (10 to 834)26 (10 to 180)26 (5 to 293)0.92
Bilirubin (mg/dL)0.7 (0.2 to 5.9)0.6 (0.2 to 6.0)0.6 (0.2 to 9.6)0.17
Albumin (g/dL)4.5 (1.9 to 5.2)4.6 (0.7 to 5.4)4.6 (0.9 to 5.8)0.04
INR1.0 (0.3 to 2.4)1.0 (0.9 to 2.5)1.1 (0.7 to 2.9)0.14
Glucose (mg/dL)99 (71 to 245)100 (64 to 212)101 (68 to 307)0.15
Vitamin D3 (ng/mL)23.1 (7.7 to 84.7)20.4 (3.0 to 59.3)22.0 (3.8 to 58.0)0.53
Immunosuppression TAC based (%)71 (92%)132 (91%)182 (92%)0.96
Bone density (n, %) 0.67
Normal45 (58.4%)73 (50.3%)97 (48.7%)
Osteopenia28 (36.4)64 (44.1%)92 (46.2%)
Osteoporosis4 (5.2%)8 (5.5%)10 (5.0%)

Group I: 6 to 12 months after OLTx; group II: 13 to 36 months after OLTx; group III: >37 months after OLTx. For continuous variables: median and range values, the Kruskal: Wallis test. For categorical data: number of observations and absolute frequencies, the Chi-square test. Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; Hb, haemoglobin; INR, international normalised ratio; TAC, tacrolimus. Conversion factors to SI units are as follows: for ALT, ALP, AST, and GGT 0.0167.

Table 2

Comparison of patient groups in terms of analysed factors affecting health-related quality of life.

FeatureGroup I (n = 77)Group II (n = 145)Group III (n = 198)p Value
SF-36 PCS (points)70 (31.25 to 83.75)67.5 (23.75 to 88.75)68.75 (26.5 to 85.0)0.99
SF-36 MCS (points)50 (31.25 to 68.75)48.75 (26.0 to 63.75)50 (21.8 to 72.5)0.06
IPAQ Total MET2316 (132 to 3978)2799 (49.5 to 41,328)2376 (99 to 37,116)0.65
IPAQ Total sitting time (minutes/week)2100 (21 to 5040)2520 (420 to 5040)2100 (14 to 5880)0.81
PHQ-9 (points)4 (0 to 27)4 (0 to 25)4 (0 to 27)0.84
MFIS Physical (points)12 (0 to 33)12 (0 to 32)11 (0 to 36)0.72
MFIS Cognitive (points)10 (0 to 34)10 (0 to 30)10 (0 to 40)0.97
MFIS Psychosocial (points)2 (0 to 8)2 (0 to 8)2 (0 to 8)0.70
MFIS Total (points)26 (0 to 62)24 (0 to 67)24 (0 to 84)0.97

Group I: 6 to 12 months after OLTx; group II: 13 to 36 months after OLTx; group III: >37 months after OLTx. Continuous variables presented as median and range. The Kruskal: Wallis test. Abbreviations: IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; PHQ-9, Patient Health Questionnaire-9; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary.

Table 3

Comparison of demographic and social data on analysed and control groups.

Study Group (n = 420)Control Group (n = 275)p Value
Age (years)53 (21 to 80)52 (20 to 88)0.23
Male gender (n, %)239 (56.9%)138 (50.2%)0.10
BMI (kg/m2)26.0 (15.6 to 41.9)26.0 (17.2 to 42.9)0.67
Employment (n, %) <0.0001
No229 (54.4%)81 (29.5%)
Yes191 (45.6%)194 (70.5%)
Health status (n, %) 0.009
Poor12 (2.8%)8 (2.9%)
Mild impairment103 (24.5%)41 (14.9%)
Good305 (72.7%)226 (82.2%)
Health-related quality of life
SF-36 PF (points)85.0 (0.0 to 100.0)95.0 (0.0 to 100.0)<0.0001
SF-36 RP (points)75.0 (0.0 to 100.0)81.5 (0.0 to 100.0)0.02
SF-36 BP (points)30.0 (0.0 to 90.0)20.0 (0.0 to 90.0)0.96
SF-36 GH (points)55.0 (5.0 to 95.0)55.0 (25.0 to 90.0)0.89
SF-36 VT (points)45.0 (20.0 to 75.0)45.0 (20.0 to 80.0)0.12
SF-36 SF (points)50.0 (0.0 to 87.5)50.0 (12.5 to 87.5)0.67
SF-36 RE (points)91.7 (0.0 to 100.0)100.0 (0.0 to 100.0)0.07
SF-36 MH (points)60.0 (25.0 to 100.0)65.0 (30.0 to 90.0)0.007
SF-36 PCS (points)68.7 (23.7 to 88.7)72.5 (23.7 to 91.2)<0.0001
SF-36 MCS (points)50.0 (21.9 to 72.5)51.2 (21.7 to 72.5)0.03
PHQ-9 (points)4 (0 to 27)3 (0 to 27)0.30
PHQ-9 category 0.4
Mild to moderate222 (52.8%)159 (57.8%)
Moderately severe168 (40.1%)97 (35.3%)
Severe30 (7.1%)19 (6.9%)
MFIS Physical (points)12 (0 to 36)10 (0 to 36)0.09
MFIS Cognitive (points)10 (0 to 40)10.0 (0 to 40)0.86
MFIS Psychosocial (points)2 (0 to 8)2.0 (0 to 8)0.63
MFIS Score (points)25 (0 to 84)23 (0 to 84)0.28
Physical activity
Physical activity <0.0001
No165 (39.2%)57 (20.7%)
Yes160 (38.0%)176 (64.0%)
Time to time96 (22.8%)42 (15.3%)
Total MET2409 (49 to 41,328)3012 (120 to 62,712)0.02
Total sitting time (minutes/week)2100 (14 to 5880)2100 (420 to 5040)0.13

For continuous variables: median and range values, the Mann: Whitney test. For categorical data: number of observations and absolute frequencies, the Chi-square test. Abbreviations: BP, bodily pain; GH, general health; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; MH, mental health; PHQ-9, Patient Health Questionnaire-9; SF, social functioning; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary; PF, physical functioning; RE, role-emotional; RP, role-physical; VT, vitality.

Table 4

Comparison of male and female patients with regard to analysed factors affecting health-related quality of life.

FeatureMales (n = 239)Females (n = 181)p Value
Age (years)52.5 (21 to 80)54 (21 to 74)0.30
BMI (kg/m2)26.7 (17.2 to 41.9)25.0 (15.6 to 40.0)0.004
SF-36 PCS (points)70.0 (23.7 to 85.0)67.5 (26.6 to 88.7)0.72
SF-36 MCS (points)50.0 (26.9 to 68.7)50.0 (21.9 to 72.5)0.79
IPAQ Total MET2550 (66 to 41,328)2376 (49 to 36,582)0.45
IPAQ Total sitting time (minutes/week)2520 (14 to 5580)2100 (21 to 5880)0.12
PHQ-9 (points)3 (0 to 27)5 (0 to 25)<0.0001
MFIS Physical (points)9 (0 to 36)16 (0 to 34)<0.0001
MFIS Cognitive (points)7 (0 to 40)13 (0 to 39)<0.0001
MFIS Psychosocial (points)2 (0 to 8)3 (0 to 8)<0.0001
MFIS Score (points)20 (0 to 84)32 (0 to 72)<0.0001

Continuous variables presented as median and range. The Mann: Whitney test. Abbreviations: IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; PHQ-9, Patient Health Questionnaire-9; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary.

Table 5

Comparison of employed and unemployed patients with regard to analysed factors affecting health-related quality of life.

FeatureUnemployed (n = 229)Employed (n = 191)p Value
Male gender (n, %)115 (50%)124 (65%)0.004
Age (years)54.3 ± 12.045.7 ± 11.9<0.0001
BMI (kg/m2)26.9 ± 4.725.8 ± 4.40.02
SF-36 PCS (points)65.0 ± 13.067.3 ± 11.80.06
SF-36 MCS (points)49.6 ± 7.649.4 ± 8.30.77
IPAQ Total MET2140 (66 to 36,582)2826 (49 to 41,328)0.008
IPAQ Total sitting time (minutes/week)2434.6 ± 1068.72533.0 ± 1099.30.36
PHQ-9 (points)6.2 ± 5.84.4 ± 4.4<0.0001
MFIS Physical (points)13.9 ± 8.59.9 ± 7.5<0.0001
MFIS Cognitive (points)12.7 ± 8.88.9 ± 7.3<0.0001
MFIS Psychosocial (points)3.0 ± 2.22.1 ± 1.8<0.0001
MFIS Score (points)29.6 ± 18.220.9 ± 15.4<0.0001

For continuous variables: median and range values, the Mann: Whitney test. For categorical data: number of observations and absolute frequencies, the Chi-square test. Abbreviations: IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; PHQ-9, Patient Health Questionnaire-9; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary.

Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results Source: 3. Results

Abstract: Conclusions

The general HRQoL of OLTx patients was similar to controls. However, patients were less physically active and more frequently unemployed. As depression and chronic fatigue occurred more often in females, particular attention should be paid to their psychiatric assessment.

Source: Conclusions
Authors’ abstract

Background/Objectives:

Over the past decades there has been a remarkable improvement in the clinical outcomes and prognoses after orthotopic liver transplantation (OLTx). Health-related quality of life (HRQoL) has emerged as an important concept for assessing the success of this procedure. We aimed to assess critical aspects of HRQoL in patients transplanted at our centre.

Methods:

We recruited 420 OLTx recipients and divided them into three groups based on the time since surgery. Two hundred and seventy-five controls were matched for age and gender. The Medical Outcomes Study Short Form (SF-36), International Physical Activity Questionnaire, Patient Health Questionnaire-9 (PHQ-9), and the Modified Fatigue Impact Scale (MFIS) were used to assess HRQoL, physical activity levels, depression, and chronic fatigue, respectively.

Results:

Compared to controls, OLTx patients exhibited grossly comparable HRQoL except for the physical component score (PCS) and mental domains of the SF-36. There was a significant correlation between the impairment of the PCS and depression and between the PCS and chronic fatigue. Physically active patients scored significantly lower in the MFIS, and there was a strong correlation between depression and chronic fatigue. Females exhibited more pronounced symptoms of depression and chronic fatigue than males but comparable physical activity levels and general QoL. Unemployed patients had significantly higher scores in the PHQ-9/MFIS.

Conclusions:

The general HRQoL of OLTx patients was similar to controls. However, patients were less physically active and more frequently unemployed. As depression and chronic fatigue occurred more often in females, particular attention should be paid to their psychiatric assessment.

Read the full paper

1. Introduction

Orthotopic liver transplantation (OLTx) remains the only curative treatment for patients with end-stage liver disease. Currently, the five-year survival in OLTx patients exceeds 80% due to substantial improvements in managing technical issues, immunosuppression, and the management of post-transplant complications. Given these advances, issues related to patient health-related quality of life (HRQoL) and mood disturbances such as depression and chronic fatigue have emerged as pivotal for assessing the true benefit of this treatment modality [1]. Depression, in particular, may be of considerable importance, as it can not only affect patients’ compliance, but it also has a stronger negative effect on patients’ HRQoL than somatic symptoms [2].

In addition, while chronic fatigue usually decreases after the procedure, it remains in a significant proportion of patients after OLTx and, for some, may be their most distressing symptom [3,4,5].

Physical activity plays a crucial role in maintaining good health. This may be particularly important in patients who have received OLTx, as many remain sedentary with no or minimal physical activity before their operation [1]. Additionally, immunosuppressive treatments may increase various metabolic risks such as hypertension, diabetes or hyperlipidaemia. A recent study has demonstrated that a lack of physical activity leading to obesity and other metabolic problems significantly affects survival in OLTx recipients [6]. Thus, objective assessments of activity levels are essential for patient long-term survival.

Returning to work should also be considered an important outcome parameter after a transplant, as it helps patients come back to everyday activities [7,8]. Unfortunately, a significant proportion of patients remain unemployed after OLTx. Currently, the literature on this subject provides conflicting data. Therefore, in this study, we aimed to assess vital factors associated with patients’ HRQoL in a large cohort of OLTx patients treated at our centre. In particular, we aimed to investigate whether the procedure has a negative impact on perceived general health by comparing scores from widely used patient-reported outcome measures (PROMs) between patients and matched controls.

Additionally, we explored whether liver transplantation significantly affects levels of physical activity. Other key areas of interest included the willingness to return to work and its potential positive influence on symptoms of depression and chronic fatigue. Finally, we examined whether gender plays a role in the prevalence or severity of common symptoms impacting health-related quality of life (HRQoL).

2. Material and Methods

2.1. Patients

The study includes 420 liver transplant recipients (239 males and 181 females) under care at our unit and out-patients clinic. These patients were age: and gender-matched to 275 (138 males and 137 females) individuals with no liver disease or serious medical conditions affecting their HRQoL. Control group was recruited from patients’ families and attendees of various courses on popular science issues conducted by the authors of this manuscript. All patients and control subjects were included in the study from October 2017 until March 2020, when the study was stopped due to the COVID-19 pandemic.

All patients were enrolled in the study at least six months after undergoing transplant surgery. Study patients were clinically stable and did not suffer from severe co-morbidities that could have significantly affected their HRQoL or physical activity, such as malignant neoplasms, uncontrolled diabetes, renal failure requiring dialysis, New York Heart Association II heart failure, physical disabilities, orthopaedic or rheumatoid joint diseases, or pulmonary diseases. Patients were divided into three groups depending on the amount of time since their OLTx: 6 to 12 months after OLTx (76 patients [18%], group I), 13 to 36 months after OLTx (145 patients [35%], group II), and >37 months after OLTx (199 [47%], group III).

Demographic data were collected using a self-developed questionnaire that included basic information regarding education, marital and financial status, existing addictions, and included simplified questions on general health and physical activity (Supplementary Materials S1 Questionnaire).

2.2. Assessment of Health-Related Quality of Life

The HRQoL was assessed using the Medical Outcomes Study Short Form (SF-36). The SF-36 is the most widely used and extensively validated generic questionnaire for assessing HRQoL in various clinical settings and populations [9]. It consists of 36 items, grouped into eight domains: physical health domains (physical functioning, role limitations due to physical problems, bodily pain, and general health) and mental health domains (vitality, social functioning, role limitations due to emotional issues, and mental health).

Each domain is scored between 0 and 100 points, with higher scores indicating better HRQoL. Two summary scores, the physical (PCS) and mental components (MCS), were obtained as a median value calculated based on the corresponding domains. This study was carried out under a licenced approval certificate (CT132326/OP012559) for the use of the SF-36 questionnaire.

2.3. Assessment of Physical Activity

To assess physical activity, the Polish long version of the International Physical Activity Questionnaire (IPAQ) [10] was used. IPAQ is an instrument for monitoring levels of physical activity of an adult population between 15 and 69 years of age and was developed for surveillance activities and to guide policy development related to health-enhancing physical activity across various life domains. The long version of the IPAQ comprises 27 items and investigates four physical activity domains (work, leisure, chores, and transport), as well as using time spent sitting as a proxy for sedentary behaviour [11].

Physical activity is reported as a continuous score by domain and intensity of the physical activity (moderate or vigorous) or walking. The energy cost of an activity was expressed in METs (metabolic equivalent tasks). A MET is the ratio of the energy expenditure during a given activity divided by the resting energy expenditure [10]. In this study, physical activity energy expenditure was calculated according to the following formula (in MET-min·week−1): number of days spent performing the activity × average duration of the activity per day × energy cost of the activity.

2.4. Assessment of Depressive Symptoms

The Patient Health Questionnaire-9 (PHQ-9) is a self-administered screening tool for depressive symptoms as defined in the Diagnostic and Statistical Manual IV and was initially designed as a part of the Primary Care Evaluation of Mental Disorders [12]. PHQ-9 scores range from 0 to 27 points. Scores of 5, 10, 15, and 20 points correlate with mild, moderate, moderately severe, and severe depression, respectively.

2.5. Assessment of Chronic Fatigue

The Modified Fatigue Impact Scale (MFIS) is a revised form of the original Fatigue Impact Scale. The Polish version was used in this study [13]. This 21-item scale provides a global score and generates three sub-scales that measure the effects of fatigue in terms of physical, cognitive and psychosocial functioning. Each item is rated by the respondent on a scale from 0 (never) to 4 (almost always). Scores are calculated for each of its three sub-scales: physical (9 items, cumulative score range 0 to 36), cognitive (10 items, cumulative score range 0 to 40), and psychosocial (2 items, cumulative score range 0 to 8) These scores are combined for a total MFIS score (range 0 to 84) [14].

2.6. Assessment of Bone Mineral Density

Bone mineral density (BMD) was measured in the lumbar spine (L1: L4) and total hip by dual-energy X-ray absorptiometry (GE Lunar Prodigy, Madison, WI, USA; software enCORE version 14.1) using automatic scan modes. Osteopenia and osteoporosis were defined according to World Health Organisation diagnostic criteria. BMD values were expressed in g/cm2 along with z-scores (standard deviation from the mean BMD for healthy, age-matched, gender-specific subjects) and t-scores (standard deviation from the mean BMD for young, healthy individuals).

2.7. Statistics

Descriptive statistical methods were used to analyse all variables. The distribution of continuous variables was visually inspected by histograms and presented as median and ranges. Categorical data are described using the number of observations and absolute frequencies. The Mann: Whitney test or the Kruskal: Wallis equality-of-populations rank test, were applied as appropriate to calculate the differences between sub-groups. Correlation analyses were performed using the Spearman rank correlation method. Prevalence comparisons between groups were performed using two-tailed Fisher’s exact test or Yates corrected Chi-squared test.

Stata 18.0 (StataCorp LLC, College Station, TX, USA) was used for all calculations and graphs. A value of p < 0.05 was considered statistically significant.

3. Results

Clinical and demographic data of the patients are summarised in Table 1 and Table 2. Comparisons between the analysed patients and the control group are shown in Table 3.

All three patient groups were comparable in terms of their demographic, clinical, and health-related quality of life factors. There was no statistically significant difference between groups when the period after OLTx was analysed concerning HRQoL, physical activity, depression, or chronic fatigue (Table 1 and Table 2).

There were also no significant differences in sociodemographic variables between patients and controls except for employment, health status, and physical activity levels, as assessed using general questions from a self-prepared questionnaire (Table 3). In the SF-36, transplant patients had significantly worse HRQoL scores than controls in the domains of physical functioning, role, physical and mental health, and in the physical and mental component scores (PCS and MCS, respectively). Transplant patients were also less physically active (Table 3).

3.1. Correlation Between HRQoL and Physical Activity, Depression, and Chronic Fatigue

For this analysis, summaries of the PCS and MCS were used. As shown in Figure 1B,C, there was a significant correlation between a pronounced impairment of the PCS and depression and between the PCS and chronic fatigue. No statistically significant correlation was seen between the PCS and physical activity as measured by the IPAQ. Additionally, there was no correlation between MCS and IPAQ, and depression and chronic fatigue. These data are summarised in Figure 1.

3.2. Correlation Between Physical Activity and Depression and Chronic Fatigue

There were negative correlations between physical activity and depressive symptoms and between physical activity and chronic fatigue (Figure 2A,B). Additionally, there was a significant correlation between physical activity and both lower glycaemia and higher vitamin D levels (Figure 2C,D).

3.3. Correlation Between Depression and Chronic Fatigue

There was a significant correlation between PHQ-9 and MFIS scores. More depressed patients complained of more pronounced chronic fatigue (Figure 3).

3.4. Comparison of Male and Female Patients

Female patients had significantly lower BMIs than males. They also had more pronounced symptoms of depression and chronic fatigue but comparable physical activity levels and general quality of life scores with males (Table 4).

3.5. Employment

Male patients were more frequently employed (65% vs. 50%, p = 0.004). Employed patients were also significantly younger and typically had a better PCS on the SF-36. Additionally, measures of depression and chronic fatigue were significantly better in employed than in unemployed subjects (Table 5).

3.6. Osteoporosis

Features of osteoporosis and osteopenia were seen in 206 (49%) patients. There was no association between bone density and post-transplant time or physical activity levels (Supplementary Table S1).

4. Discussion

In this study, we focused on the factors affecting the health-related quality of life of patients who underwent OLTx by analysing a large cohort of patients at our centre. To the best of our knowledge, this is the largest group of post-liver transplant patients investigated for HRQoL variables reported from a single centre. We have a long-lasting interest in various aspects of quality of life factors in patients with various liver conditions both before and after a transplant [15,16,17].

Our main findings can be summarised as follows: (i) liver transplantation does not appear to have a substantial impact on overall health-related quality of life (HRQoL); (ii) patients who have undergone liver transplantation are generally less physically active compared to carefully matched controls; (iii) transplant recipients who return to work after surgery tend to report lower levels of depression and chronic fatigue; and (iv) female patients tend to experience higher levels of depression and chronic fatigue than their male counterparts following the transplant procedure.

Indeed, when compared to age: and gender-matched controls, our patients had comparable HRQoL scores except for the PCS and MCS on the SF-36. This finding confirms the results of previous studies that have found impaired physical and mental coping strategies after surgery [18]. It has been shown that the majority of patients are more concerned about their HRQoL than longevity [18]. Hence, OLTx should aim to lead patients to a normal HRQoL, while impaired physical functioning should focus our attention on this issue and ways to improve it [19,20,21].

Of note, the patients in our study did not report more pronounced symptoms of depression or chronic fatigue compared to controls, which is in contrast to other findings [22].

It has been demonstrated that during the first six months after a liver transplant, a majority of HRQoL factors show significant improvement. Therefore, in this study, we included only patients who had undergone transplant surgery at least six months previously. We divided these patients into three groups depending on the post-surgical period, i.e., between 6 and 12 months, between 12 and 36 months, and above 37 months. These groups were comparable in terms of their clinical status and liver biochemistry.

Furthermore, they did not differ regarding the analysed parameters of health-related quality of life. These results allowed us to use the entire group of transplanted patients for further analyses.

Physical activity is of particular importance in patients who undergo OLTx, as it not only improves general health but also exerts a positive effect on HRQoL [1,23,24,25]. However, an adequate methodology for the precise assessment of physical activity in transplant patients is lacking. This problem has recently been defined as a key unmet need in contemporary transplant hepatology [1]. It has been postulated that liver transplant teams should evaluate the fitness of their patients at discharge and design realistic, long-term exercise programmes aimed at achieving standards that have been established for the general population.

This is of critical importance given a recent study that has highlighted the increasing proportion of physically inactive patients at risk of metabolic problems [6]. That study demonstrated that as many as 73% of transplant patients are either overweight or obese, leading to significantly increased post-transplant mortality [6]. Our study showed that higher physical activity levels correlated with lower chronic fatigue. This confirms previous findings from a study investigating a small group of patients from the Netherlands [3] and further supports the observation that physical exercise alleviates fatigue and improves QoL [5].

We also found a trend towards a correlation between physical activity and better scores in the PHQ-9, which suggests physical activity may have a protective effect against depression. This finding is in line with observations in liver transplant patients [5,22] and in non-transplant settings [26,27,28]. We also found a significant correlation between physical activity and lower glycaemia and higher vitamin D3 levels, confirming the beneficial effects of physical activity on metabolic status.

Several studies have shown that female patients with various health conditions have a worse HRQoL [29,30,31]. The reasons for this remain to be elucidated. While our study found that general HRQoL was not impaired in females after receiving a transplant, there was a striking difference regarding depression and chronic fatigue, with female patients scoring higher in both depression and chronic fatigue questionnaires than males. This finding requires further investigation, preferably with studies that involve a psychologist, to obtain further insight into this phenomenon.

The main aims of liver transplantation are to increase the length and quality of a patient’s life and enable their return to normal life, including work [8,32]. Resuming full productivity should be considered an essential outcome parameter after a solid organ transplant, as it is associated with returning to normal social life, accomplishing personal goals, and improving financial status and self-esteem [33,34]. Although the majority of liver transplants are performed on subjects of working age, a significant proportion do not return to work.

Various studies have shown that between 22% and 60% of patients restart work after OLTx [35,36,37]. A large study based on United Network for Organ Sharing data, which included nearly 22,000 patients, found that only 24% were employed within 24 months after the procedure [8]. The demographic variables independently associated with employment included work activity before OLTx, age between 18 and 40 years, being male, having a college degree, and being Caucasian.

Patients receiving transplants for alcoholic liver disease also had the lowest rate of employment when compared to other indications. While a detailed analysis of this issue was not the main goal of our study, we found that approximately 45% of our patients were employed. Similarly to other studies, males and younger patients were more likely to return to work. We also found that HRQoL, as measured with the SF-36, was comparable between employed and unemployed subjects. Employment also showed a highly significant correlation with lower fatigue scores and less depression in the PHQ-9.

Thus, returning to work appears to have a positive effect on a patient’s mood and fatigue levels, although depression and pronounced fatigue may also preclude commencing employment.

This study has some limitations. First, this was a cross-sectional design. Second, the patients were divided into three groups based on the time after transplantation, and despite these being large cohorts, each group consisted of different patients, which may have decreased the value of our findings. Third, as the data were obtained from patient self-reporting, there may be some bias. Finally, there are no transplant-specific HRQoL questionnaires; thus, most studies, including this one, use generic forms such as the SF-36 or the PHQ-9.

In conclusion, this study showed that important markers of health-related quality of life are similar between liver transplant patients and healthy individuals, confirming that OLTx is both life-saving and offers patients an adequate HRQoL. Unfortunately, transplant patients were also found to be less physically active. Therefore, efforts should be made to encourage these patients to undertake regular exercise. Returning to work had a positive effect on patients, potentially reducing depression and chronic fatigue. As female patients were more frequently depressed and chronically fatigued, adequate counselling and, if necessary, proper treatment should be considered.

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/jcm14134507/s1, Figure S1. Correlation between physical activity and depression and chronic fatigue. A negative correlation between physical activity and depressive symptoms and between physical activity and chronic fatigue was observed (1A and 1B). There was also a correlation between physical activity and both lower glycaemia and higher vitamin D levels (1C and 1D); Table S1. Comparison of patients with normal bone density, osteopenia and osteoporosis with regards to analyzed factors affecting Health Related Quality of Life Bone density; Supplementary Materials S1: Questionnaire.

Supplement file at the original source: open the original paper. This file is not included in this text import.

Author Contributions

Conceptualization, P.M. and K.K.; methodology, P.M., K.K., and J.M.; validation, K.K. and E.W.; formal analysis, E.W.; investigation, K.K., M.W., P.M., and J.P.; resources, J.R.-W., K.K., and J.P.; data curation, K.K., M.W., and J.P.; writing: original draft preparation, P.M.; writing: review and editing, K.K. and E.W.; visualisation, E.W.; supervision, P.M., J.M., and J.R.-W.; project administration, K.K.; funding acquisition, K.K. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Warsaw Medical University (protocol approval no. KB/A/79/2014 from 15 April 2014).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data available on request due to ethical and legal restrictions (data protection rules).

Conflicts of Interest

The authors declare no conflicts of interest.

References

1. Dunn M.A. Rogal S.S. Duarte-Rojo A. Lai J.C. Physical Function, Physical Activity, and Quality of Life After Liver Transplantation Liver Transpl. 2020 26 702 708 10.1002/lt.25742 32128971 PMC8063858
2. Nickel R. Wunsch A. Egle U.T. Lohse A.W. Otto G. The relevance of anxiety, depression, and coping in patients after liver transplantation Liver Transpl. 2002 8 63 71 10.1053/jlts.2002.30332 11799488
3. van den Berg-Emons R.J. van Ginneken B.T. Nooijen C.F. Metselaar H.J. Tilanus H.W. Kazemier G. Stam H.J. Fatigue after liver transplantation: Effects of a rehabilitation program including exercise training and physical activity counseling Phys. Ther. 2014 94 857 865 10.2522/ptj.20130402 24557657
4. van den Berg-Emons R. van Ginneken B. Wijffels M. Tilanus H. Metselaar H. Stam H. Kazemier G. Fatigue is a major problem after liver transplantation Liver Transpl. 2006 12 928 933 10.1002/lt.20684 16528681
5. van Ginneken B.T. van den Berg-Emons R.J. van der Windt A. Tilanus H.W. Metselaar H.J. Stam H.J. Kazemier G. Persistent fatigue in liver transplant recipients: A two-year follow-up study Clin. Transplant. 2010 24 E10 E16 10.1111/j.1399-0012.2009.01083.x 19744096
6. van Son J. Stam S.P. Gomes-Neto A.W. Oste M.C.J. Blokzijl H. van den Berg A.P. Porte R.J. Bakker S.J.L. de Meijer V.E. Post-transplant obesity impacts long-term survival after liver transplantation Metabolism 2020 106 154204 10.1016/j.metabol.2020.154204 32173406
7. Saab S. Wiese C. Ibrahim A.B. Peralta L. Durazo F. Han S. Yersiz H. Farmer D.G. Ghobrial R.M. Goldstein L.I. Employment and quality of life in liver transplant recipients Liver Transpl. 2007 13 1330 1338 10.1002/lt.21247 17763388
8. Huda A. Newcomer R. Harrington C. Blegen M.G. Keeffe E.B. High rate of unemployment after liver transplantation: Analysis of the United Network for Organ Sharing database Liver Transpl. 2012 18 89 99 10.1002/lt.22408 21837745
9. Ware J.E. Jr. Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med. Care 1992 30 473 483 10.1097/00005650-199206000-00002 1593914
10. Kim Y. Park I. Kang M. Convergent validity of the international physical activity questionnaire (IPAQ): Meta-analysis Public Health Nutr. 2013 16 440 452 10.1017/S1368980012002996 22874087 PMC10271683
11. Bergier J. Studies and measurements of physical activity of the society Ann. Agric. Environ. Med. 2012 19 329 331 23020019
12. Kroenke K. Spitzer R.L. Williams J.B. The PHQ-9: Validity of a brief depression severity measure J. Gen. Intern. Med. 2001 16 606 613 10.1046/j.1525-1497.2001.016009606.x 11556941 PMC1495268
13. Gruszczak A. Bartosik-Psujek H. Pocinska K. Stelmasiak Z. Validation analysis of selected psychometric features of Polish version of Modified Fatigue Impact Scale--preliminary findings Neurol. Neurochir. Pol. 2009 43 148 154 19484692
14. Fisk J.D. Ritvo P.G. Ross L. Haase D.A. Marrie T.J. Schlech W.F. Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale Clin. Infect. Dis. 1994 18 (Suppl. 1) S79 S83 10.1093/clinids/18.Supplement_1.S79 8148458
15. Janik M.K. Wunsch E. Raszeja-Wyszomirska J. Moskwa M. Kruk B. Krawczyk M. Milkiewicz P. Autoimmune hepatitis exerts a profound, negative effect on health-related quality of life: A prospective, single-centre study Liver Int. 2019 39 215 221 10.1111/liv.13960 30204306
16. Raszeja-Wyszomirska J. Wunsch E. Krawczyk M. Rigopoulou E.I. Kostrzewa K. Norman G.L. Bogdanos D.P. Milkiewicz P. Assessment of health related quality of life in polish patients with primary biliary cirrhosis Clin. Res. Hepatol. Gastroenterol. 2016 40 471 479 10.1016/j.clinre.2015.10.006 26621536
17. Wunsch E. Stadnik A. Kruk B. Szczepankiewicz B. Kotarska K. Krawczyk M. Gornicka B. Wojcicki M. Milkiewicz P. Chronic Fatigue Persists in a Significant Proportion of Female Patients After Transplantation for Primary Sclerosing Cholangitis Liver Transpl. 2021 27 1032 1040 10.1002/lt.26033 33641247
18. Yang L.S. Shan L.L. Saxena A. Morris D.L. Liver transplantation: A systematic review of long-term quality of life Liver Int. 2014 34 1298 1313 10.1111/liv.12553 24703371
19. Onghena L. Develtere W. Poppe C. Geerts A. Troisi R. Vanlander A. Berrevoet F. Rogiers X. Van Vlierberghe H. Verhelst X. Quality of life after liver transplantation: State of the art World J. Hepatol. 2016 8 749 756 10.4254/wjh.v8.i18.749 27366301 PMC4921796
20. Drent G. De Geest S. Dobbels F. Kleibeuker J.H. Haagsma E.B. Symptom experience, nonadherence and quality of life in adult liver transplant recipients Neth. J. Med. 2009 67 161 168 19581664
21. Butt Z. Parikh N.D. Skaro A.I. Ladner D. Cella D. Quality of life, risk assessment, and safety research in liver transplantation: New frontiers in health services and outcomes research Curr. Opin. Organ. Transplant. 2012 17 241 247 10.1097/MOT.0b013e32835365c6 22476225 PMC3740962
22. Jing W. Bi C. Fang Z. Qian C. Chen J. Yu J. Tian G. Ye M. Liu Z. Neuropsychiatric sequelae after liver transplantation and their possible mechanism via the microbiota-gut-liver-brain axis Biomed. Pharmacother. 2023 163 114855 10.1016/j.biopha.2023.114855 37163780
23. De Smet S. O’Donoghue K. Lormans M. Monbaliu D. Pengel L. Does Exercise Training Improve Physical Fitness and Health in Adult Liver Transplant Recipients? A Systematic Review and Meta-analysis Transplantation 2023 107 e11 e26 10.1097/TP.0000000000004313 36192838
24. Rongies W. Stepniewska S. Lewandowska M. Smolis-Bak E. Dolecki W. Sierdzinski J. Trzepla E. Cholewinska G. Stankiewicz W. Physical activity long-term after liver transplantation yields better quality of life Ann. Transplant. 2011 16 126 131 10.12659/AOT.882005 21959520
25. Dunn M.A. Josbeno D.A. Schmotzer A.R. Tevar A.D. DiMartini A.F. Landsittel D.P. Delitto A. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates Liver Transpl. 2016 22 1324 1332 10.1002/lt.24506 27348200
26. Singh B. Olds T. Curtis R. Dumuid D. Virgara R. Watson A. Szeto K. O’Connor E. Ferguson T. Eglitis E. Effectiveness of physical activity interventions for improving depression, anxiety and distress: An overview of systematic reviews Br. J. Sports Med. 2023 57 1203 1209 10.1136/bjsports-2022-106195 36796860 PMC10579187
27. Biyyala D. Joseph R. Varadharajan N. Krishnamoorthy Y. Menon V. Incidence and prevalence of depressive, anxiety, and insomnia symptoms among adult liver transplant recipients: A systematic review and meta-analysis Gen. Hosp. Psychiatry 2023 80 26 34 10.1016/j.genhosppsych.2022.12.003 36549018
28. Noetel M. Sanders T. Gallardo-Gomez D. Taylor P. Del Pozo Cruz B. van den Hoek D. Smith J.J. Mahoney J. Spathis J. Moresi M. Effect of exercise for depression: Systematic review and network meta-analysis of randomised controlled trials BMJ 2024 384 e075847 10.1136/bmj-2023-075847 38355154 PMC10870815
29. Fonseca A.F. Lahoz R. Proudfoot C. Corda S. Loefroth E. Jackson J. Cotton S. Studer R. Burden and Quality of Life Among Female and Male Patients with Heart Failure in Europe: A Real-World Cross-Sectional Study Patient Prefer. Adherence 2021 15 1693 1706 10.2147/PPA.S312200 34354345 PMC8331086
30. Mundet L. Ribas Y. Arco S. Clave P. Quality of Life Differences in Female and Male Patients with Fecal Incontinence J. Neurogastroenterol. Motil. 2016 22 94 101 10.5056/jnm15088 26486375 PMC4699726
31. Boecking B. Biehl R. Brueggemann P. Mazurek B. Health-Related Quality of Life, Depressive Symptoms, Anxiety, and Somatization Symptoms in Male and Female Patients with Chronic Tinnitus J. Clin. Med. 2021 10 2798 10.3390/jcm10132798 34202097 PMC8267833
32. Chen P.X. Yan L.N. Wang W.T. Health-related quality of life of 256 recipients after liver transplantation World J. Gastroenterol. 2012 18 5114 5121 10.3748/wjg.v18.i36.5114 23049223 PMC3460341
33. Adams P.C. Ghent C.N. Grant D.R. Wall W.J. Employment after liver transplantation Hepatology 1995 21 140 144 10.1002/hep.1840210124 7806148
34. Cowling T. Jennings L.W. Goldstein R.M. Sanchez E.Q. Chinnakotla S. Klintmalm G.B. Levy M.F. Societal reintegration after liver transplantation: Findings in alcohol-related and non-alcohol-related transplant recipients Ann. Surg. 2004 239 93 98 10.1097/01.sla.0000103064.34233.94 14685106 PMC1356198
35. Moyzes D. Walter M. Rose M. Neuhaus P. Klapp B.F. Return to work 5 years after liver transplantation Transplant. Proc. 2001 33 2878 2880 10.1016/S0041-1345(01)02225-4 11498195
36. Rongey C. Bambha K. Vanness D. Pedersen R.A. Malinchoc M. Therneau T.M. Dickson E.R. Kim W.R. Employment and health insurance in long-term liver transplant recipients Am. J. Transplant. 2005 5 1901 1908 10.1111/j.1600-6143.2005.00961.x 15996237
37. Sahota A. Zaghla H. Adkins R. Ramji A. Lewis S. Moser J. Sher L.S. Fong T.L. Predictors of employment after liver transplantation Clin. Transplant. 2006 20 490 495 10.1111/j.1399-0012.2006.00511.x 16842527
Figure 1

Correlation between HRQoL and physical activity, depression, and chronic fatigue. PCS and MCS were analysed. Spearman rank correlation. There was a significant correlation between the impairment of the PCS and depression, and between the PCS and chronic fatigue (B,C). No statistically significant correlation was seen between the PCS and physical activity as measured by the IPAQ (A). There was also no correlation between MCS and IPAQ, and depression and chronic fatigue (DNot reportedF).

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 2

Correlation between physical activity and depression and chronic fatigue. Spearman rank correlation. A negative correlation between physical activity and depressive symptoms and between physical activity and chronic fatigue was observed (A,B). There was also a correlation between physical activity and both lower glycaemia and higher vitamin D levels (C,D).

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 3

Correlation between depression and chronic fatigue. Spearman rank correlation. A significant correlation between PHQ-9 and MFIS scores was observed. Patients who were more depressed also reported more pronounced chronic fatigue.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Clinical and demographic data on analysed groups of patients.

FeatureGroup I (n = 77)Group II (n = 145)Group III (n = 198)p Value
Age (years)49 (21 to 70)54 (21 to 80)54 (21 to 74)0.14
Male gender (n, %)45 (58.4%)81 (56.3%)113 (56.8%)0.88
BMI (kg/m2)25.2 (18.2 to 35.5)26.5 (17.9 to 41.9)26.1 (15.6 to 39.0)0.14
Aetiology (n, %) 0.04
Alcohol-related18 (23.4%)31 (21.4%)24 (12.2%)
Autoimmune30 (39.0%)41 (28.3%)65 (33.0%)
Viral8 (10.3%)39 (26.9%)49 (24.8%)
Other21 (27.3%)34 (23.4%)59 (30.0%)
Biochemistry
Hb (g/dL)13.4 (9.2 to 17.6)13.9 (8.1 to 17.6)14.0 (8.6 to 19.2)0.03
Platelets (tys/μL)174 (109 to 404)180 (104 to 402)179 (100 to 429)0.93
AST (IU/L)25 (12 to 319)25 (2 to 505)26 (11 to 555)0.49
ALT (IU/L)28 (10 to 834)26 (10 to 180)26 (5 to 293)0.92
Bilirubin (mg/dL)0.7 (0.2 to 5.9)0.6 (0.2 to 6.0)0.6 (0.2 to 9.6)0.17
Albumin (g/dL)4.5 (1.9 to 5.2)4.6 (0.7 to 5.4)4.6 (0.9 to 5.8)0.04
INR1.0 (0.3 to 2.4)1.0 (0.9 to 2.5)1.1 (0.7 to 2.9)0.14
Glucose (mg/dL)99 (71 to 245)100 (64 to 212)101 (68 to 307)0.15
Vitamin D3 (ng/mL)23.1 (7.7 to 84.7)20.4 (3.0 to 59.3)22.0 (3.8 to 58.0)0.53
Immunosuppression TAC based (%)71 (92%)132 (91%)182 (92%)0.96
Bone density (n, %) 0.67
Normal45 (58.4%)73 (50.3%)97 (48.7%)
Osteopenia28 (36.4)64 (44.1%)92 (46.2%)
Osteoporosis4 (5.2%)8 (5.5%)10 (5.0%)

Group I: 6 to 12 months after OLTx; group II: 13 to 36 months after OLTx; group III: >37 months after OLTx. For continuous variables: median and range values, the Kruskal: Wallis test. For categorical data: number of observations and absolute frequencies, the Chi-square test. Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; Hb, haemoglobin; INR, international normalised ratio; TAC, tacrolimus. Conversion factors to SI units are as follows: for ALT, ALP, AST, and GGT 0.0167.

Table 2

Comparison of patient groups in terms of analysed factors affecting health-related quality of life.

FeatureGroup I (n = 77)Group II (n = 145)Group III (n = 198)p Value
SF-36 PCS (points)70 (31.25 to 83.75)67.5 (23.75 to 88.75)68.75 (26.5 to 85.0)0.99
SF-36 MCS (points)50 (31.25 to 68.75)48.75 (26.0 to 63.75)50 (21.8 to 72.5)0.06
IPAQ Total MET2316 (132 to 3978)2799 (49.5 to 41,328)2376 (99 to 37,116)0.65
IPAQ Total sitting time (minutes/week)2100 (21 to 5040)2520 (420 to 5040)2100 (14 to 5880)0.81
PHQ-9 (points)4 (0 to 27)4 (0 to 25)4 (0 to 27)0.84
MFIS Physical (points)12 (0 to 33)12 (0 to 32)11 (0 to 36)0.72
MFIS Cognitive (points)10 (0 to 34)10 (0 to 30)10 (0 to 40)0.97
MFIS Psychosocial (points)2 (0 to 8)2 (0 to 8)2 (0 to 8)0.70
MFIS Total (points)26 (0 to 62)24 (0 to 67)24 (0 to 84)0.97

Group I: 6 to 12 months after OLTx; group II: 13 to 36 months after OLTx; group III: >37 months after OLTx. Continuous variables presented as median and range. The Kruskal: Wallis test. Abbreviations: IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; PHQ-9, Patient Health Questionnaire-9; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary.

Table 3

Comparison of demographic and social data on analysed and control groups.

Study Group (n = 420)Control Group (n = 275)p Value
Age (years)53 (21 to 80)52 (20 to 88)0.23
Male gender (n, %)239 (56.9%)138 (50.2%)0.10
BMI (kg/m2)26.0 (15.6 to 41.9)26.0 (17.2 to 42.9)0.67
Employment (n, %) <0.0001
No229 (54.4%)81 (29.5%)
Yes191 (45.6%)194 (70.5%)
Health status (n, %) 0.009
Poor12 (2.8%)8 (2.9%)
Mild impairment103 (24.5%)41 (14.9%)
Good305 (72.7%)226 (82.2%)
Health-related quality of life
SF-36 PF (points)85.0 (0.0 to 100.0)95.0 (0.0 to 100.0)<0.0001
SF-36 RP (points)75.0 (0.0 to 100.0)81.5 (0.0 to 100.0)0.02
SF-36 BP (points)30.0 (0.0 to 90.0)20.0 (0.0 to 90.0)0.96
SF-36 GH (points)55.0 (5.0 to 95.0)55.0 (25.0 to 90.0)0.89
SF-36 VT (points)45.0 (20.0 to 75.0)45.0 (20.0 to 80.0)0.12
SF-36 SF (points)50.0 (0.0 to 87.5)50.0 (12.5 to 87.5)0.67
SF-36 RE (points)91.7 (0.0 to 100.0)100.0 (0.0 to 100.0)0.07
SF-36 MH (points)60.0 (25.0 to 100.0)65.0 (30.0 to 90.0)0.007
SF-36 PCS (points)68.7 (23.7 to 88.7)72.5 (23.7 to 91.2)<0.0001
SF-36 MCS (points)50.0 (21.9 to 72.5)51.2 (21.7 to 72.5)0.03
PHQ-9 (points)4 (0 to 27)3 (0 to 27)0.30
PHQ-9 category 0.4
Mild to moderate222 (52.8%)159 (57.8%)
Moderately severe168 (40.1%)97 (35.3%)
Severe30 (7.1%)19 (6.9%)
MFIS Physical (points)12 (0 to 36)10 (0 to 36)0.09
MFIS Cognitive (points)10 (0 to 40)10.0 (0 to 40)0.86
MFIS Psychosocial (points)2 (0 to 8)2.0 (0 to 8)0.63
MFIS Score (points)25 (0 to 84)23 (0 to 84)0.28
Physical activity
Physical activity <0.0001
No165 (39.2%)57 (20.7%)
Yes160 (38.0%)176 (64.0%)
Time to time96 (22.8%)42 (15.3%)
Total MET2409 (49 to 41,328)3012 (120 to 62,712)0.02
Total sitting time (minutes/week)2100 (14 to 5880)2100 (420 to 5040)0.13

For continuous variables: median and range values, the Mann: Whitney test. For categorical data: number of observations and absolute frequencies, the Chi-square test. Abbreviations: BP, bodily pain; GH, general health; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; MH, mental health; PHQ-9, Patient Health Questionnaire-9; SF, social functioning; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary; PF, physical functioning; RE, role-emotional; RP, role-physical; VT, vitality.

Table 4

Comparison of male and female patients with regard to analysed factors affecting health-related quality of life.

FeatureMales (n = 239)Females (n = 181)p Value
Age (years)52.5 (21 to 80)54 (21 to 74)0.30
BMI (kg/m2)26.7 (17.2 to 41.9)25.0 (15.6 to 40.0)0.004
SF-36 PCS (points)70.0 (23.7 to 85.0)67.5 (26.6 to 88.7)0.72
SF-36 MCS (points)50.0 (26.9 to 68.7)50.0 (21.9 to 72.5)0.79
IPAQ Total MET2550 (66 to 41,328)2376 (49 to 36,582)0.45
IPAQ Total sitting time (minutes/week)2520 (14 to 5580)2100 (21 to 5880)0.12
PHQ-9 (points)3 (0 to 27)5 (0 to 25)<0.0001
MFIS Physical (points)9 (0 to 36)16 (0 to 34)<0.0001
MFIS Cognitive (points)7 (0 to 40)13 (0 to 39)<0.0001
MFIS Psychosocial (points)2 (0 to 8)3 (0 to 8)<0.0001
MFIS Score (points)20 (0 to 84)32 (0 to 72)<0.0001

Continuous variables presented as median and range. The Mann: Whitney test. Abbreviations: IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; PHQ-9, Patient Health Questionnaire-9; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary.

Table 5

Comparison of employed and unemployed patients with regard to analysed factors affecting health-related quality of life.

FeatureUnemployed (n = 229)Employed (n = 191)p Value
Male gender (n, %)115 (50%)124 (65%)0.004
Age (years)54.3 ± 12.045.7 ± 11.9<0.0001
BMI (kg/m2)26.9 ± 4.725.8 ± 4.40.02
SF-36 PCS (points)65.0 ± 13.067.3 ± 11.80.06
SF-36 MCS (points)49.6 ± 7.649.4 ± 8.30.77
IPAQ Total MET2140 (66 to 36,582)2826 (49 to 41,328)0.008
IPAQ Total sitting time (minutes/week)2434.6 ± 1068.72533.0 ± 1099.30.36
PHQ-9 (points)6.2 ± 5.84.4 ± 4.4<0.0001
MFIS Physical (points)13.9 ± 8.59.9 ± 7.5<0.0001
MFIS Cognitive (points)12.7 ± 8.88.9 ± 7.3<0.0001
MFIS Psychosocial (points)3.0 ± 2.22.1 ± 1.8<0.0001
MFIS Score (points)29.6 ± 18.220.9 ± 15.4<0.0001

For continuous variables: median and range values, the Mann: Whitney test. For categorical data: number of observations and absolute frequencies, the Chi-square test. Abbreviations: IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent task; MCS, Mental Component Summary; MFIS, Modified Fatigue Impact Scale; PHQ-9, Patient Health Questionnaire-9; SF-36, Medical Outcomes Study Short Form; PCS, Physical Component Summary.

Publication and source details

Original title: Factors Affecting Health-Related Quality of Life in Patients After a Liver Transplant: A Cross-Sectional, Single-Centre, Large-Cohort Study

Katarzyna Kotarska; Ewa Wunsch; Jerzy Przedlacki; Maciej Wójcicki; Joanna Raszeja-Wyszomirska; Jolanta Małyszko; Piotr Milkiewicz

Journal of Clinical Medicine · 2025

* Correspondence: ewa.wunsch@pum.edu.pl© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:20:54.286538+00:00

DOI: 10.3390/jcm14134507 · PMC12249576